Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
1 other identifier
observational
50,000
1 country
1
Brief Summary
The study aims to establishing the diagnosis standard of POI and analyzing the risk factors in Chinese women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 13, 2017
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMay 8, 2018
May 1, 2017
5 years
June 13, 2017
April 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of serum FSH levels
the serum FSH levels between day 2 to day 5 of menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.
through study completion, an average of 3 months, assessed up to 48 months
Menstruation situation
the length of the menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.
through study completion, an average of 3 months, assessed up to 48 months
Secondary Outcomes (2)
Change of Antral follicle count
through study completion, an average of 3 months, assessed up to 48 months
Change of anti-mullerian hormone levels
through study completion, an average of 3 months, assessed up to 48 months
Eligibility Criteria
Female under the condition of diminished ovarian reserve were enrolled in the study. The condition of diminished ovarian reserve may be the early stage of premature ovarian insufficiency.
You may qualify if:
- Infertility
- The length of menstrual cycle longer than 35 days or shorter than/amenorrhea
- Serum FSH levels ≥10mIU/ml/ serum AMH levels ≤1.0pg/ml/ AFC ≤7, on at least two occasion \>4 weeks apart
You may not qualify if:
- Polycystic Ovarian Syndrome
- other causes of amenorrhea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nanfang Hospital, Southern Medical Universitylead
- Queen Mary Hospital, Hong Kongcollaborator
- Southern Medical University, Chinacollaborator
- The Third Affiliated Hospital of Southern Medical Universitycollaborator
- Shenzhen Hospital of Southern Medical Universitycollaborator
- Shen-Zhen City Maternity and Child Healthcare Hospitalcollaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicinecollaborator
Study Sites (1)
Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shi-ling Chen, M.D, Ph.D
Nanfang Hospital, Southern Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2017
First Posted
May 8, 2018
Study Start
September 1, 2016
Primary Completion
September 1, 2021
Study Completion
December 1, 2021
Last Updated
May 8, 2018
Record last verified: 2017-05